(Q43694465)

English

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Richard T. Ngomba

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Ferdinando Nicoletti

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Valeria Maria Gloria Bruno

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

M D'Onofrio

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Cuomo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Battaglia

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Storto

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A E Kingston

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Orzi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A De Blasi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Di Iorio

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Journal of Neurochemistry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

78

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

435-445

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483646%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

A synthetic inhibitor of the mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

TGF-beta 1 is an organizer of responses to neurodegeneration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Transforming growth factor-betas in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

TGF-beta signalling through the Smad pathway

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Transforming growth factor-beta protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-beta type II receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

TGF-beta1 prevents gp120-induced impairment of Ca2+ homeostasis and rescues cortical neurons from apoptotic death.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Use of pharmacological agents in elucidating the mechanism of insulin action.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Transforming growth factor-beta is a survival factor for neonate cortical neurons: coincident expression of type I receptors in developing cerebral cortices.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

The TGF-beta family and its composite receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

A Transforming Growth Factor-β Antagonist Unmasks the Neuroprotective Role of This Endogenous Cytokine in Excitotoxic and Ischemic Brain Injury

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00435.X

21 January 2018

Mitotic signaling by beta-amyloid causes neuronal death

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1046/J.1471-4159.2001.00435.X

Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1046/J.1471-4159.2001.00435.X

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1046/J.1471-4159.2001.00435.X

The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1046/J.1471-4159.2001.00435.X

Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1046/J.1471-4159.2001.00435.X

Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1046/J.1471-4159.2001.00435.X

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43694465&oldid=2102632473"